207 related articles for article (PubMed ID: 17013900)
1. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
[TBL] [Abstract][Full Text] [Related]
2. Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Int J Cancer; 2012 Jan; 130(1):48-58. PubMed ID: 21618217
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
[TBL] [Abstract][Full Text] [Related]
4. Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.
Kanno H; Watabe D; Shimizu N; Sawai T
Clin Exp Immunol; 2008 Mar; 151(3):519-27. PubMed ID: 18190605
[TBL] [Abstract][Full Text] [Related]
5. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
6. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.
Yoshimori M; Imadome K; Komatsu H; Wang L; Saitoh Y; Yamaoka S; Fukuda T; Kurata M; Koyama T; Shimizu N; Fujiwara S; Miura O; Arai A
PLoS One; 2014; 9(11):e112564. PubMed ID: 25409517
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.
Tsuge I; Morishima T; Morita M; Kimura H; Kuzushima K; Matsuoka H
Clin Exp Immunol; 1999 Mar; 115(3):385-92. PubMed ID: 10193407
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
[TBL] [Abstract][Full Text] [Related]
9. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
[TBL] [Abstract][Full Text] [Related]
10. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites.
Suzuki D; Tsuji K; Yamamoto T; Fujii K; Iwatsuki K
Exp Hematol; 2010 Oct; 38(10):933-44. PubMed ID: 20600581
[TBL] [Abstract][Full Text] [Related]
11. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
12. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
Sun R; Li AL; Wei HM; Tian ZG
Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
[TBL] [Abstract][Full Text] [Related]
13. EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.
Huang WT; Lin CW
Am J Pathol; 2014 Apr; 184(4):1185-97. PubMed ID: 24655378
[TBL] [Abstract][Full Text] [Related]
14. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
16. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H
Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
19. Differential cytokine expression in EBV positive peripheral T cell lymphomas.
Ho JW; Liang RH; Srivastava G
Mol Pathol; 1999 Oct; 52(5):269-74. PubMed ID: 10748876
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]